Remote Care Versus Routine Monitoring for COPD Patients Using Home Breathing Support
Compares active remote care with monitoring alone in COPD patients using home breathing support.
Plain-language title generated from the registry record
Registry title: Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
Key facts
- Where
- Changsha, Hangzhou, Wenling, and Zhengzhou, ChinaSee the 4 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 80 years old?
Source: NCT07751003, who can take part
Where in China
- The Second Xiangya Hospital of Central South UniversityChangsha, ChinaNo longer taking part
- Sir Run Run Shaw Hospital, School of Medicine, Zhejiang UniversityHangzhou, ChinaNo longer taking part
- Taizhou Hospital of Integrated Traditional Chinese and Western MedicineWenling, ChinaNo longer taking part
- Henan Provincial People's HospitalZhengzhou, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sir Run Run Shaw Hospital
- Trial code
- NCT07751003
- Record updated
- 6 August 2026
- Original description
This study is a randomized controlled trial designed to compare the effectiveness of active remote intervention versus passive monitoring alone in patients with Chronic Obstructive Pulmonary Disease (COPD) and chronic hypercapnic respiratory failure who are receiving home non-invasive respiratory support. The primary goal is to evaluate the impact on health-related quality of life and the frequency of acute exacerbations over a 12-month period.Read full original descriptionShow less
A Randomized Controlled Trial of Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
This study is a randomized controlled trial designed to compare the effectiveness of active remote intervention versus passive monitoring alone in patients with Chronic Obstructive Pulmonary Disease (COPD) and chronic hypercapnic respiratory failure who are receiving home non-invasive respiratory support. The primary goal is to evaluate the impact on health-related quality of life and the frequency of acute exacerbations over a 12-month period.
Inclusion: Meets the diagnostic criteria for Chronic Obstructive Pulmonary Disease (COPD) with confirmed persistent airflow limitation by spirometry; Hospitalized due to an acute exacerbation of COPD; Stable daytime arterial blood gas analysis showing PaCO₂ ≥ 50 mmHg, with hypoxemia; Already receiving or planned to receive long-term home non-invasive respiratory support; Capable of using a smartphone or tablet for video communication and has internet access; Willing to participate and provides written informed consent.
Exclusion: Concurrent severe pulmonary diseases (e.g., active tuberculosis, diffuse pulmonary fibrosis, advanced lung cancer); Chronic respiratory failure primarily caused by non-COPD conditions (e.g., neuromuscular disease, chest wall deformity, or severe obesity hypoventilation syndrome); Severe cognitive impairment or psychiatric illness that would prevent cooperation with remote management; Other severe systemic diseases with an expected survival of less than 1 year (e.g., advanced malignancy); Pregnant or lactating women.